Magnetar Financial LLC acquired a new stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 18,502 shares of the medical instruments supplier's stock, valued at approximately $276,000.
A number of other hedge funds also recently bought and sold shares of XRAY. Mirae Asset Global Investments Co. Ltd. acquired a new stake in DENTSPLY SIRONA in the 1st quarter valued at about $25,000. Colonial Trust Co SC purchased a new stake in shares of DENTSPLY SIRONA in the 4th quarter valued at approximately $26,000. Brooklyn Investment Group purchased a new stake in shares of DENTSPLY SIRONA in the 1st quarter valued at approximately $26,000. Caitong International Asset Management Co. Ltd grew its stake in shares of DENTSPLY SIRONA by 8,003.6% in the 1st quarter. Caitong International Asset Management Co. Ltd now owns 2,269 shares of the medical instruments supplier's stock valued at $34,000 after buying an additional 2,241 shares during the period. Finally, Allworth Financial LP grew its stake in shares of DENTSPLY SIRONA by 175.8% in the 1st quarter. Allworth Financial LP now owns 3,949 shares of the medical instruments supplier's stock valued at $54,000 after buying an additional 2,517 shares during the period. Institutional investors and hedge funds own 95.70% of the company's stock.
DENTSPLY SIRONA Trading Up 2.0%
Shares of NASDAQ:XRAY traded up $0.29 during mid-day trading on Friday, reaching $14.62. 2,056,381 shares of the company were exchanged, compared to its average volume of 3,190,562. The company has a debt-to-equity ratio of 1.13, a current ratio of 1.69 and a quick ratio of 1.11. The firm has a market cap of $2.92 billion, a price-to-earnings ratio of -3.08, a P/E/G ratio of 0.91 and a beta of 0.96. The firm's 50-day simple moving average is $14.99 and its 200 day simple moving average is $15.19. DENTSPLY SIRONA Inc. has a 1 year low of $12.16 and a 1 year high of $27.48.
DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last posted its quarterly earnings data on Thursday, August 7th. The medical instruments supplier reported $0.52 earnings per share for the quarter, topping analysts' consensus estimates of $0.50 by $0.02. The firm had revenue of $936.00 million during the quarter, compared to analysts' expectations of $929.67 million. DENTSPLY SIRONA had a negative net margin of 25.85% and a positive return on equity of 16.33%. The firm's quarterly revenue was down 4.9% on a year-over-year basis. During the same quarter last year, the company posted $0.49 EPS. DENTSPLY SIRONA has set its FY 2025 guidance at 1.800-2.000 EPS. Equities research analysts forecast that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current year.
DENTSPLY SIRONA Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Friday, October 10th. Shareholders of record on Friday, September 26th will be given a $0.16 dividend. This represents a $0.64 annualized dividend and a yield of 4.4%. The ex-dividend date of this dividend is Friday, September 26th. DENTSPLY SIRONA's dividend payout ratio (DPR) is currently -13.50%.
Wall Street Analyst Weigh In
Several analysts have recently weighed in on the stock. Wall Street Zen cut shares of DENTSPLY SIRONA from a "buy" rating to a "hold" rating in a research note on Saturday, August 9th. Stifel Nicolaus dropped their price target on shares of DENTSPLY SIRONA from $19.00 to $17.00 and set a "hold" rating for the company in a research note on Friday, August 8th. Needham & Company LLC reissued a "hold" rating on shares of DENTSPLY SIRONA in a research note on Monday, July 21st. UBS Group dropped their price target on shares of DENTSPLY SIRONA from $25.00 to $24.00 and set a "buy" rating for the company in a research note on Friday, August 8th. Finally, Barrington Research dropped their price target on shares of DENTSPLY SIRONA from $21.00 to $18.00 and set an "outperform" rating for the company in a research note on Friday, August 8th. Two research analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the stock. Based on data from MarketBeat.com, DENTSPLY SIRONA presently has an average rating of "Hold" and an average target price of $18.64.
Check Out Our Latest Stock Analysis on XRAY
About DENTSPLY SIRONA
(
Free Report)
DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.
Further Reading
Before you consider DENTSPLY SIRONA, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DENTSPLY SIRONA wasn't on the list.
While DENTSPLY SIRONA currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
